Unapproved peptide products not included in the Australian Register of Therapeutic Goods include those containing BPC157, GHKCu, TB500, retatrutide and CJC1295, often supplied in injectable form
PMID 3121137
Strong communication, fast processing and transparent product documentation
Chinese manufacturers use similar innovations to produce pharmaceutical HGH products under the same or even higher conditions, and they are significantly more effective
The severity of the side effects is dependent on the administered dosage
The data needed to derive the three component shares (work, PE, and MP) are more aggregated than the specialty-level PE/HR data required for the PE methodology, so we have fewer concerns with the small sample sizes for this application